Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Mayo Clinic
Mayo Clinic
Stanford University
Fred Hutchinson Cancer Center
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
University of Washington
City of Hope Medical Center
Mayo Clinic
Mayo Clinic
University of Michigan Rogel Cancer Center
Emory University
Mayo Clinic
Mayo Clinic
University of Arizona
Thomas Jefferson University
M.D. Anderson Cancer Center
UNICANCER
Abramson Cancer Center at Penn Medicine
Vanderbilt-Ingram Cancer Center
Bispebjerg Hospital
The Netherlands Cancer Institute
Regina Elena Cancer Institute
Netherlands Working Group on Immunotherapy of Oncology
Fred Hutchinson Cancer Center
Mayo Clinic
The Christie NHS Foundation Trust
Centre Hospitalier Universitaire de Saint Etienne
The Netherlands Cancer Institute
Mayo Clinic
University of Pittsburgh
The Netherlands Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
The Cleveland Clinic
University of Virginia
Assistance Publique - Hôpitaux de Paris
Yale University
Vanderbilt-Ingram Cancer Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OHSU Knight Cancer Institute
Duke University
Boston University
Assistance Publique Hopitaux De Marseille
Ruhr University of Bochum
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic